Journal article
Retinal Degeneration 3 (RD3) Protein Inhibits Catalytic Activity of Retinal Membrane Guanylyl Cyclase (RetGC) and Its Stimulation by Activating Proteins
Biochemistry (Easton), v 50(44), pp 9511-9519
08 Nov 2011
PMID: 21928830
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Retinal membrane guanylyl cyclase (RetGC) in the outer segments of vertebrate photoreceptors is controlled by guanylyl cyclase activating proteins (GCAPs), responding to light-dependent changes of the intracellular Ca2+ concentrations. We present evidence that a different RetGC binding protein, retinal degeneration 3 protein (RD3), is a high-affinity allosteric modulator of the cyclase which inhibits RetGC activity at submicromolar concentrations. It suppresses the basal activity of RetGC in the absence of GCAPs in a noncompetitive manner, and it inhibits the GCAP-stimulated RetGC at low intracellular Ca2+ levels. RD3 opposes the allosteric activation of the cyclase by GCAP but does not significantly change Ca2+ sensitivity of the GCAP-dependent regulation. We have tested a number of mutations in RD3 implicated in human retinal degenerative disorders and have found that several mutations prevent the stable expression of RD3 in HEK293 cells and decrease the affinity of RD3 for RetGC1. The RD3 mutant lacking the carboxy-terminal half of the protein and associated with Leber congenital amaurosis type 12 (LCA12) is unable to suppress the activity of the RetGC1/GCAP complex. Furthermore, the inhibitory activity of the GS7V mutant implicated in cone rod degeneration is strongly reduced. Our results suggest that inhibition of RetGC by RD3 may be utilized by photoreceptors to block RetGC activity during its maturation and/or incorporation into the photoreceptor outer segment rather than participate in dynamic regulation of the cyclase by Ca2+ and GCAPs.
Metrics
Details
- Title
- Retinal Degeneration 3 (RD3) Protein Inhibits Catalytic Activity of Retinal Membrane Guanylyl Cyclase (RetGC) and Its Stimulation by Activating Proteins
- Creators
- Igor V. Peshenko - Drexel University Elkins Park CampusElena V. Olshevskaya - Drexel University Elkins Park CampusSeifollah Azadi - University of British ColumbiaLaurie L. Molday - University of British ColumbiaRobert S. Molday - University of British ColumbiaAlexander M. Dizhoor - Drexel University Elkins Park Campus
- Publication Details
- Biochemistry (Easton), v 50(44), pp 9511-9519
- Publisher
- Amer Chemical Soc
- Number of pages
- 9
- Grant note
- Pennsylvania Department of Health R01EY002422 / NATIONAL EYE INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI) EY11522; EY02422 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Neurobiology and Anatomy; Pennsylvania College of Optometry (PCO)
- Web of Science ID
- WOS:000296304200010
- Scopus ID
- 2-s2.0-80155203814
- Other Identifier
- 991022035262404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- International collaboration
- Web of Science research areas
- Biochemistry & Molecular Biology